Live Chart

O 656.9

H 656.9

L 656.9

VOL 25

Medicamen Biotech Overview

Days Range

Low: ₹645.00
High: ₹662.15
Previous Close ₹655.60
Open ₹656.90
Volume 2,525
Day’s Range ₹645.00 - ₹662.15
52W Range ₹598.05 - ₹1,078.00
Market Cap ₹831.05 Cr

Fundamentals of Medicamen Biotech

ROCE (TTM) 9.18%
P/E Ratio (TTM) 53.84
P/B Ratio 4.36
Industry P/E 32.55
Debt to Equity 0.13
ROE 7.67%
EPS (TTM) 12.2
Dividend Yield 0.15%
Book Value 151
Face Value 10

Financials of Medicamen Biotech

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales33.5335.5838.6741.94
Expenses29.331.3133.836.68
Profit before tax4.144.224.364.68
Operating Profit3.63.773.773.95
Net Profit3.63.773.773.95
EPS in Rs2.852.983.033.12

About Medicamen Biotech

Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company i ... Read More

Parent Organisation Indian Private
Founded 1993
Managing Director Rahul Bishnoi
NSE Symbol MEDICAMEQ

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,259.15

288.15

7.25 (2.58%)

278 - 290.9
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹51.58

46.9

0.00 (0.00)

44.1 - 46.9
Procter & Gamble Health Ltd ₹8,487.00

5100.35

12.55 (-0.25%)

5029.15 - 5137.9
Veerhealth Care Ltd ₹40.86

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Medicamen Biotech (MEDICAMEQ)?

Medicamen Biotech (MEDICAMEQ) share price as of October 3, 2023, on NSE is Rs 651.15 (NSE) and Rs 653.10 (BSE) on BSE.

Can I buy Medicamen Biotech (MEDICAMEQ) shares?

Yes, You can buy Medicamen Biotech (MEDICAMEQ) shares by opening a Demat account with Angel One.

How do I buy Medicamen Biotech (MEDICAMEQ) from Angel One?

Medicamen Biotech (MEDICAMEQ) share can be brought through the following modes:
  1. Direct investment: You can buy Medicamen Biotech (MEDICAMEQ) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Medicamen Biotech (MEDICAMEQ) shares.